2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | ANTIVIRAL RESEARCH ANTIVIR RES (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.6
50人评分
我要评分
声誉 8.7 影响力 6.4 速度 9.4 | |||||||||||||||||||||||||||||||
期刊ISSN | 0166-3542 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||
E-ISSN | 1872-9096 | |||||||||||||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 4.5 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
实时影响因子 | 截止2024年10月29日:3.017 | |||||||||||||||||||||||||||||||
2023-2024自引率 | 4.40%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
五年影响因子 | 5 | |||||||||||||||||||||||||||||||
JCI期刊引文指标 | 1.76 | |||||||||||||||||||||||||||||||
h-index | 108 | |||||||||||||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||
期刊官方网站 | http://www.journals.elsevier.com/antiviral-research/ | |||||||||||||||||||||||||||||||
期刊投稿网址 | https://www.editorialmanager.com/AVR | |||||||||||||||||||||||||||||||
期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足ANTIVIRAL RESEARCH的语言要求,还能让ANTIVIRAL RESEARCH编辑和审稿人得到更好的审稿体验,让稿件最大限度地被ANTIVIRAL RESEARCH编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(1篇) 论文致谢(3篇) 。 提交文稿 | |||||||||||||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||||||||||||
通讯方式 | ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE | |||||||||||||||||||||||||||||||
出版商 | Elsevier | |||||||||||||||||||||||||||||||
涉及的研究方向 | 医学-病毒学 | |||||||||||||||||||||||||||||||
出版国家或地区 | NETHERLANDS | |||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||
出版周期 | Monthly | |||||||||||||||||||||||||||||||
出版年份 | 1981 | |||||||||||||||||||||||||||||||
年文章数 | 185点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
Gold OA文章占比 | 44.99% | |||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 99.46% | |||||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0166-3542%5BISSN%5D | |||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均3.0个月 来源Elsevier官网: 平均9.6周 | |||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 约25% | |||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在ANTIVIRAL RESEARCH顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||||||||
在线出版周期 | 来源Elsevier官网: 平均2.9周 | |||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Ciliatoside A, isolated from Peristrophe japonica, inhibits HBsAg expression and cccDNA transcription by inducing autophagy Author: Fang, Ren; Ming, Tan; Ng, Jerome P. L.; Guo, Wu An; Yu, Yuan Si; Hui, Zhang; Hua, Ren Ji; Tao, Cheng Sheng; Juan, Zhang; Hong, Lo Hang; Wong, Vincent Kam Wai; Law, Betty Yuen Kwan; Juan, Chen Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105482 PubMed DOI |
2. | Multiplication of defective Ebola virus in a complementary permissive cell line Author: Tong, Xian-Kun; Li, Heng; Yang, Li; Xie, Shi-Zhe; Xie, Sha; Gong, Ying; Peng, Cheng; Gao, Xiao-Xiao; Shi, Zheng-Li; Yang, Xing-Lou; Zuo, Jian-Ping Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105491 PubMed DOI |
3. | Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster Author: Zhang, Ya-Nan; Zhang, Hong-Qing; Wang, Gui-Feng; Zhang, Zhe-Rui; Li, Jia-Qi; Chen, Xiao-Ling; Hu, Yan-Yan; Zeng, Xiang-Yue; Shi, Yu-Jia; Wang, Jing; Li, Ying-Hua; Li, Xiao-Dan; Wang, Chun-He; Zhu, Bing; Zhang, Bo Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105507 PubMed DOI |
4. | PI3K/AKT-mediated autophagy inhibition facilitates mast cell activation to enhance severe inflammatory lung injury in influenza A virus- and secondary Staphylococcus aureus-infected mice Author: Tang, Yuling; Su, Ruijing; Gu, Qingyue; Hu, Yanxin; Yang, Hanchun Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105502 PubMed DOI |
5. | A new intracellular targeting motif in the cytoplasmic tail of the spike protein may act as a target to inhibit SARS-CoV-2 assembly Author: Hu, Longbo; Tang, Yongjie; Mei, Lingling; Liang, Mengdi; Huang, Jinxian; Wang, Xufei; Wu, Liping; Jiang, Jiajing; Li, Leyi; Long, Fei; Xiao, Jing; Tan, Long; Lu, Shaohua; Peng, Tao Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105509 PubMed DOI |
6. | ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway Author: Yang, Qingyu; Wu, Chengyuan; Zhu, Guangyan; Ren, Fuli; Lin, Binbin; Huang, Rui; Hu, Xujuan; Zhao, Dingran; Peng, Ke; Wang, Qiongya; Huang, Chaolin; Zhang, Dingyu Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105498 PubMed DOI |
7. | Targeting 7-dehydrocholesterol reductase against EV-A71 replication by upregulating interferon response Author: Wang, Huiqiang; Cui, Boming; Yan, Haiyan; Wu, Shuo; Wang, Kun; Yang, Ge; Jiang, Jiandong; Li, Yuhuan Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105497 PubMed DOI |
8. | Identification of critical residues in the regulatory protein HBx for Smc5/6 interaction and hepatitis B virus production Author: He, Lili; Shen, Huanyu; Deng, Hui; Zhang, Xiaoyan; Xu, Yang; Shi, Chunwei; Ouyang, Zhuqing Journal: ANTIVIRAL RESEARCH. 2023; Vol. 211, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105519 PubMed DOI |
9. | Influenza antivirals and their role in pandemic preparedness Author: Jones, Jeremy C.; Yen, Hui-Ling; Adams, Peter; Armstrong, Kimberly; Govorkova, Elena A. Journal: ANTIVIRAL RESEARCH. 2023; Vol. 210, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105499 PubMed DOI |
10. | Development of highly effective LCB1-based lipopeptides targeting the spike receptor-binding motif of SARS-CoV-2 Author: Zhu, Yuanmei; Li, Min; Liu, Nian; Wu, Tong; Han, Xuelian; Zhao, Guangyu; He, Yuxian Journal: ANTIVIRAL RESEARCH. 2023; Vol. 211, Issue , pp. -. DOI: 10.1016/j.antiviral.2023.105541 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室